Isaac S. Kohane, MD, PhD, chair of the Department of Biomedical Informatics at Harvard Medical School, discusses promising uses and the path forward for artificial intelligence (AI) in health care.
Leemore S. Dafny, PhD, the Bruce V. Rauner Professor of Business Administration at Harvard Business School, discusses provider consolidation, the CVS-Aetna merger and the potential impact of Big Tech on health care consolidation.
Margaret “Molly” Hayes, MD, associate director of the Internal Medicine Residency Training Program and assistant director of the medical intensive care unit at Beth Israel Deaconess Medical Center (BIDMC), discusses handling uncertainty in critical care decision-making.
Amit V. Khera, MD, MSc, associate director of the Precision Medicine Unit at the Massachusetts General Hospital Center for Genomics Medicine and the Cardiovascular Disease Initiative at the Broad Institute, discusses the potential impact of polygenic scores.
Zirui Song, MD, PhD, an assistant professor of health care policy and medicine at Harvard Medical School and an internal medicine physician at Massachusetts General Hospital, discusses workplace wellness programs.
Mara Bloom, JD, MS, the executive director of Mass General Cancer Center, discusses the future of cancer care delivery, grappling with cost, and access to clinical trials.
Justin F. Gainor, MD, director of targeted immunotherapy at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, answers three questions about cancer immunotherapy.
Hera Vlamakis, PhD, senior group leader for the Infectious Disease and Microbiome Program at the Broad Institute, discusses the expanding impact of gut microbiome research.
Elaine B. Goodman, MD, MBA, medical director of the Medical Walk-In Unit at Massachusetts General Hospital and associate chief medical officer at Wellframe, discusses sustained engagement and impact for digital health solutions.
Michael Chernew, director of the Healthcare Markets and Regulation Lab at Harvard Medical School, discusses intersections between approaches to slowing health care spending and real-world experience.
